.Pharmacolibrary.Drugs.C_CardiovascularSystem.C08D_SelectiveCalciumChannelBlockersWithDirectCardiac.C08DA01_Verapamil.Verapamil_1 .Pharmacolibrary.Drugs.C_CardiovascularSystem.C08D_SelectiveCalciumChannelBlockersWithDirectCardiac.C08DA01_Verapamil.Verapamil_1| name: | Verapamil_1 |
| ATC code: | C08DA01_1 | route: | intravenous |
| n-compartments | 2 |
Verapamil is a calcium channel blocker used therapeutically to treat hypertension, angina pectoris, and certain arrhythmias such as supraventricular tachycardia. It is approved for use and remains in clinical use today.
Pharmacokinetic parameters after intravenous bolus administration in healthy adult males.
Kaisbain, N, et al., & Kaisbain, V (2023). Verapamil-Induced Hypotension in End-Stage Renal Disease: The Role of Calcium Gluconate. Cureus 15(1) e33341–None. DOI:10.7759/cureus.33341 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36741660
Abernethy, DR (1989). The pharmacokinetic profile of amlodipine. American heart journal 118(5 Pt 2) 1100–1103. DOI:10.1016/0002-8703(89)90834-x PUBMED:https://pubmed.ncbi.nlm.nih.gov/2530866
Klotz, U (1998). Effect of age on pharmacokinetics and pharmacodynamics in man. International journal of clinical pharmacology and therapeutics 36(11) 581–585. PUBMED:https://pubmed.ncbi.nlm.nih.gov/9849746